Antibody Design

CB-101: An innovative TSAxTAAxCD3 trispecific TCE antibody for solid tumors making undruggable target druggable by widening the therapeutic window

CB-201: An innovative TSAxCD3xCD28 co-stimulatory trispecific TCE antibody for solid tumors making undruggable target druggable by enhancing efficacy without increasing  toxicity

CB-301: Trispecific antibodies to avoid antigen escape in liquid tumors and autoimmune diseases